Foundayo™ (Orforglipron) FDA Approved: What NJ Patients Should Know About the New GLP-1 Pill for Weight Loss

The FDA approved Foundayo™ (orforglipron) on April 1, 2026 — a new once-daily GLP-1 weight loss pill from Eli Lilly. If you've been curious about GLP-1 medications but not looking for weekly injections, here’s what you need to know about the newest oral version.

Estimated reading time: 6 minutes

Key Takeaways

• Foundayo™ is available now via LillyDirect® with a prescription from a doctor, with retail pharmacy availability scheduled after April 6th, 2026.
• Foundayo™ (orforglipron) was FDA approved for weight loss on April 1, 2026 for adults with obesity or overweight with a weight-related health condition
• Foundayo™ is the only GLP-1 pill that can be taken once daily at any time — no food or water restrictions required.
• In Foundayo™ clinical trials, patients lost an average of 27.3 lbs (11-12.4% body weight) at the highest dose over 72 weeks.

What Is Foundayo™ and How Does it Work?

Foundayo™ (orforglipron) is the first GLP-1 weight loss pill that you take once a day with no restrictions on when you eat or drink before taking it. It was developed by Eli Lilly, the same company that makes the injectable GLP-1 Zepbound® (tirzepatide).²Foundayo™ (orforglipron) works similarly to Zepbound® by targeting the same GLP-1 pathway. It belongs to a class of medications that work by slowing digestion, reducing appetite and inducing weight loss. This helps people feel fuller for longer and reduces food noise.

How Much Weight Can You Lose with Foundayo™ ?

Clinical trial data shows Foundayo™ helped people lose an average of 12.4% of their body weight with an average weight loss of 25 lbs. ^1,9 Results vary based on starting weight, dose, lifestyle factors, and how long you stay on treatment. To calculate your potential weight loss on  GLP-1 medications, try our potential weight loss calculator. 

Who Is Foundayo™ For?

Foundayo™ may be a good fit if you:

• Want a pill instead of a weekly injection²
• Have been putting off GLP-1 weight loss therapy because of needle concerns²
• Are already on an injectable GLP-1 and looking for a convenient long-term maintenance option³
• Have had trouble with other oral weight loss medications that required strict food or water timing^2,9

Foundayo™ is FDA-approved for adults with obesity (body mass index (BMI) greater than or equal to 30), or adults who are overweight (BMI greater than or equal to 27) with at least one weight-related medical condition such as high blood pressure, type 2 diabetes, or high cholesterol — used alongside a reduced-calorie diet and increased physical activity.⁸

How Does Foundayo™ Compare to the Wegovy® Pill and Qsymia®?

Results vary. These are clinical trial averages, not guaranteed outcomes. No head-to-head trials between Foundayo™ and oral Wegovy® have been conducted to date.

When is Foundayo™ Available?

Foundayo™ is available now, with a prescription from your doctor, through LillyDirect® with home shipping starting April 6, followed by broad availability at U.S. retail pharmacies shortly after.¹⁰

Foundayo™ is available in six doses ranging from 0.8 mg to 17.2 mg. Patients start at the lowest dose and gradually increase based on their response and tolerability, under their provider's guidance.⁸

Ready to Find Out If Foundayo™ Is Right for You?

Schedule a consultation with our team. We offer a personalized medical weight loss approach   that includes nutritional education,  muscle preservation exercise classes,  progress tracking and accountability and long term maintenance support.

Common Questions About Foundayo™

1. Is Foundayo™ available now?
Yes — Foundayo™ was approved by the FDA on April 1, 2026. It is available immediately via LillyDirect® and will be available at retail pharmacies and telehealth providers shortly after April 6.¹⁰

2. Do I need a prescription for Foundayo™?
Yes. A licensed provider needs to evaluate whether it's right for you before prescribing Foundayo™.²

3. Will my insurance cover Foundayo™?
Insurance coverage for Foundayo™ depends on your plan. Eligible commercially insured patients may pay as little as $25/month. Our team can help with prior authorization and figuring out your options.₁₀

4. Can I take Foundayo™ after bariatric surgery?
Depending on your individual situation, Foundayo™ might be a good option after bariatric surgery. Our bariatric and medical weight loss teams work together to determine what's safe and appropriate for you.

5. What are the most common side effects?
The most common side effects of Foundayo™ are nausea, constipation, diarrhea, vomiting, indigestion, stomach pain, headache, fatigue, belching, heartburn, gas, and hair loss. These are similar to other GLP-1 medications and tend to be mild, especially as your body adjusts. Foundayo™ also carries a boxed warning for thyroid tumors — discuss your personal and family medical history with your provider before starting.^8,10

6. Can Foundayo™ be used with other GLP-1 medications like Wegovy® or Zepbound®?
No. Use of Foundayo™ with other GLP-1 receptor agonist medicines is not recommended. Taking more than one GLP-1 medication at the same time significantly increases the risk of side effects._¹⁰ These medications all work the same.

References

1. Eli Lilly and Company. Lilly's oral GLP-1, orforglipron, is successful in third Phase 3 trial, triggering global regulatory submissions this year for the treatment of obesity. PR Newswire. August 26, 2025. https://www.prnewswire.com/news-releases/lillys-oral-glp-1-orforglipron-is-successful-in-third-phase-3-trial-triggering-global-regulatory-submissions-this-year-for-the-treatment-of-obesity-302538028.html
   
2. Eli Lilly and Company. What to know about orforglipron. Lilly.com. Updated December 2025. https://www.lilly.com/news/stories/what-to-know-about-orforglipron
   
3. Eli Lilly and Company. Lilly's orforglipron helped people maintain weight loss after switching from injectable incretins to oral GLP-1 therapy in first-of-its-kind Phase 3 trial. PR Newswire. December 18, 2025. https://investor.lilly.com/news-releases/news-release-details/lillys-orforglipron-helped-people-maintain-weight-loss-after
   
4. Manalac T. Lilly's obesity pill maintains weight loss as estimated approval timelines inch closer. BioSpace. December 18, 2025. https://www.biospace.com/drug-development/lillys-obesity-pill-maintains-weight-loss-as-estimated-approval-timelines-inch-closer
   
5. Devitt C. Lilly obesity pill, headed for quick FDA review, hits mark in "maintenance" trial. BioPharma Dive. December 18, 2025. https://www.biopharmadive.com/news/eli-lilly-orforglipron-maintenance-study-national-priority-voucher-fda/808250/
   
6. Jennings S. Eli Lilly's oral GLP-1RA maintains weight loss from injectable drugs. Clinical Trials Arena. December 19, 2025. https://www.clinicaltrialsarena.com/news/eli-lilly-orforglipron-phase-iii-obesity-weight-maintenance-trial/
   
7. Fallon M. FDA approves oral semaglutide as first GLP-1 pill for weight loss. AJMC. February 2026. https://www.ajmc.com/view/fda-approves-oral-semaglutide-as-first-glp-1-pill-for-weight-loss
   
8. U.S. Food and Drug Administration. FDA approves first new molecular entity under National Priority Voucher program. FDA.gov. April 1, 2026. https://www.fda.gov/news-events/press-announcements/fda-approves-first-new-molecular-entity-under-national-priority-voucher-program
   
9. Eli Lilly and Company. FDA approves Lilly's Foundayo™ (orforglipron), the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions. PR Newswire. April 1, 2026. https://www.prnewswire.com/news-releases/fda-approves-lillys-foundayo-orforglipron-the-only-glp-1-pill-for-weight-loss-that-can-be-taken-any-time-of-day-without-food-or-water-restrictions-302731485.html
   
10. Drugs.com. Foundayo (orforglipron) — dosage, side effects, uses & review. Drugs.com. April 1, 2026. https://www.drugs.com/foundayo.html

This blog is for informational purposes only and is not a substitute for personalized medical advice. Please consult a qualified healthcare provider before starting any new medication.

• Amazon’s New GLP-1 Program: What It Covers And What Else to Consider
• Foundayo™ (Orforglipron) FDA Approved: What NJ Patients Should Know About the New GLP-1 Pill for Weight Loss
• Can I Start GLP‑1 Medications and Have Bariatric Surgery Later? When Does It Make Sense to Switch?
• Is Pork Roll/Taylor Ham GLP-1 Friendly? A Dietitian’s Guide to NJ’s Iconic Breakfast Food
• Gastric Sleeve and Weight Loss - 4 Facts